Bli medlem
Bli medlem

Du är här


Ossur Hf : Board decisions following the Annual General Meeting 10 March 2016

Announcement from Össur hf. No. 30/2016

Reykjavik, 10 March 2016

Allocation of responsibilities

Mr. Niels Jacobsen was re-elected as Chairman of the Board of Directors and Dr. Kristján Tómas Ragnarsson was re-elected as Vice Chairman.

Mr. Arne Boye Nielsen, Mrs. Guðbjörg Edda Eggertsdóttir and Dr. Svafa Grönfeldt were appointed to the Company's Audit Committee.

Authorization for management to purchase own shares on behalf of the Company

With reference to the authorizations to purchase own shares approved by the Company's Annual General Meeting in 2015 and to initiate share buyback programs approved by the Company's Annual General Meeting held today, the Board granted management an authorization to purchase own shares on behalf of the Company in one or more transactions or through share buyback programs.

Terms and conditions:
* A purchase shall be made with the aim to maintain a healthy balance sheet
and a level of net interest bearing debt of 0.5x-1.5x to EBITDA in
accordance the Company's Corporate Structure and Dividend Policy approved
by the Board in February 2016.
* The purchase price shall not be higher than the price of the last
independent trade or the highest current independent bid, whichever is
higher, on the regulated market where the transaction is carried out.
* A purchase shall always be carried out within the limits of the relevant
authorization of the Annual General Meeting and in accordance with
applicable law and rules.
The authorization is valid until the next Annual General Meeting in 2017.
Össur press releases by e-mail

If you wish to receive Össur press releases by e-mail please register at the
following web-site:

About Össur

Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopaedics that help
people live a life without limitations. Its business is focused on improving
people's mobility through the delivery of innovative technologies within the
fields of braces, supports and prosthetic limbs. A recognized "Technology
Pioneer", Össur invests significantly in research and product development;
its award-winning designs ensuring a consistently strong position in the
market. Successful patient and clinical outcomes are further empowered via
educational programs and business solutions. Headquartered in Iceland, Össur
has major operations in the Americas, Europe and Asia, with additional
distributors worldwide.

Forward-Looking Statements

This press release includes "forward-looking statements" which involve risks
and uncertainties that could cause actual results to differ materially from
results expressed or implied by these statements. Össur hf. undertakes no
obligation and does not intend to update these forward-looking statements to
reflect events or circumstances occurring after this press release. You are
cautioned not to place undue reliance on these forward-looking statements,
which speak only as of the date of this press release. All forward-looking
statements are qualified in their entirety by this cautionary statement.


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Ossur Hf via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.